Prevalence of metabolic syndrome and serum marker levels in patients with four subtypes of cerebral infarction in Japan

Journal of Clinical Neuroscience

Volumn 15, Issue 7, 2008, Pages 769-773

  Yokokawa, Hirohide ^a   Goto, Aya ^a   Terui, Kazushi ^b   Funami, Yoshinari ^b   Watanabe, Kazuo ^b   Yasumura, Seiji ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b Southern Tohoku General Hospital and Southern Tohoku Research Institute for Neuroscience   (Japan)

Author keywords

Cerebral infarction; Cross sectional study; Metabolic syndrome

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LIPOPROTEIN A; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; BRAIN INFARCTION; CROSS-SECTIONAL STUDY; DIAGNOSTIC IMAGING; DISEASE MARKER; EMBOLISM; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; IMAGE ANALYSIS; JAPAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN INFARCTION; C-REACTIVE PROTEIN; CEREBRAL INFARCTION; CHOLESTEROL, HDL; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; INTRACRANIAL EMBOLISM; JAPAN; LIPOPROTEIN(A); MALE; METABOLIC SYNDROME X; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS;

EID: 44249083442     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2006.11.012     Document Type: Article

References (28)

1. Sarti C., Rastenyte D., Cepaitis Z., et al. International trends in mortality from stroke, 1968 to 1994. Stroke 31 (2000) 1588-1601
2. Kazui S., Kimura K., Minematsu K., et al. Multicenter survey on clinical features and regional variations in acute brain infarction. Rinsho Shinkeigaku 42 (2002) 736-744 (in Japanese)
3. Kobayashi S. Data bank project for acute stroke patients. Rinsho Shinkeigaku 42 (2002) 1176-1178 (in Japanese)
4. Rost N.S., Wolf P.A., Kase C.S., et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 32 (2001) 2575-2579
5. Iso H., Moriyama Y., Sato S., et al. Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese. Circulation 109 (2004) 2766-2772
6. Arenillas J.F., Molina C.A., Chacon P., et al. High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology 63 (2004) 27-32
7. Cote R., Wolfson C., Solymoss S., et al. Hemostatic markers in patients at risk of cerebral ischemia. Stroke 31 (2000) 1856-1862
8. Lindgren A., Lindoff C., Norrving B., et al. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients. Stroke 27 (1996) 1066-1071
9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
10. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
11. Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Definition and diagnostic criteria of Metabolic Syndrome. Nippon Naika Gakkai Zassi 2005;94:794-809 (in Japanese).
12. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
13. McNeill A.M., Rosamond W.D., Girman C.J., et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28 (2005) 385-390
14. Koren-Morag N., Goldbourt U., and Tanne D. Relation between the metabolic syndrome and ischemic stroke or transient ischemic attack: a prospective cohort study in patients with atherosclerotic cardiovascular disease. Stroke 36 (2005) 1366-1371
15. Kawamoto R., Tomita H., Oka Y., et al. Metabolic syndrome as a predictor of ischemic stroke in elderly persons. Intern Med 44 (2005) 922-927
16. Petty G.W., Brown Jr. R.D., Whisnant J.P., et al. Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke 30 (1999) 2513-2516
17. Caplan L.R., Gorelick P.B., and Hier D.B. Race, sex and occlusive cerebrovascular disease: a review. Stroke 17 (1986) 648-655
18. Saposnik G., Caplan L.R., Gonzalez L.A., et al. Differences in stroke subtypes among natives and caucasians in Boston and Buenos Aires. Stroke 31 (2000) 2379-2385
19. Kolominsky-Rabas P.L., Weber M., Gefeller O., et al. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 32 (2001) 2735-2740
20. Kimura K., Kazui S., Minematsu K., et al. Analysis of 16,922 patients with acute ischemic stroke and transient ischemic attack in Japan. A hospital-based prospective registration study. Cerebrovasc Dis 18 (2004) 47-56
21. Yokota C., Minematsu K., Hasegawa Y., et al. Long-term prognosis, by stroke subtypes, after a first-ever stroke: a hospital-based study over a 20-year period. Cerebrovasc Dis 18 (2004) 1111-1116
22. Arboix A., Garcia-Eroles L., Oliveres M., et al. Clinical predictors of early embolic recurrence in presumed cardioembolic stroke. Cerebrovasc Dis 8 (1998) 345-353
23. Timsit S.G., Sacco R.L., Mohr J.P., et al. Brain infarction severity differs according to cardiac or arterial embolic source. Neurology 43 (1993) 728-733
24. Petty G.W., Brown Jr. R.D., Whisnant J.P., et al. Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence. Stroke 31 (2000) 1062-1068
25. Meigs J.B., Mittleman M.A., Nathan D.M., et al. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA 283 (2000) 221-228
26. Takeuchi H., Saitoh S., Takagi S., et al. Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men-the Tanno and Sobetsu Study. Hypertens Res 28 (2005) 203-208
27. Ishizaka N., Ishizaka Y., Toda E., et al. Hypertension is the most common component of metabolic syndrome and the greatest contributor to carotid arteriosclerosis in apparently healthy Japanese individuals. Hypertens Res 28 (2005) 27-34
28. Ministry of Health, Labour and Welfare. Outline of People's Health and Nutrition 2003. http://www.mhlw.go.jp/houdou/2005/04/h0421-1.html (Accessed April 21, 2005) (in Japanese).